How can patients participate in clinical trials of cannabis for ankylosing spondylitis? 

As cannabis innovation progresses, clinical trials are becoming a vital bridge between anecdotal success and scientific validation. For patients with ankylosing spondylitis, participating in these trials not only contributes to the wider medical community but also offers early access to new treatments and personalised monitoring. 

The growing number of collaborative trials often includes partnerships between academic institutions, biotech companies, and patient networks. These projects typically rely on voluntary patient participation, which has become easier thanks to online platforms and advocacy groups that help match patients with suitable studies. Additionally, these initiatives have gained strength through persistent advocacy efforts pushing for more inclusive, ethical, and transparent research structures. 

Steps to Get Involved in Clinical Trials 

Here’s how you can become part of this evolving space in cannabis innovation: 

Register with research databases 

Sign up with trial registries like the NIHR or ClinicalTrials.gov to receive study alerts. 

Engage with patient organisations 

Groups advocating for AS and cannabis innovation often have direct links to collaborative trials. 

Consult with your healthcare provider 

Medical professionals can advise on trial suitability based on your condition and treatment history. 

Follow credible sources 

Stay updated on new trials through scientific journals, advocacy newsletters, and sites like AlleviMed. 

Visit providers like LeafEase to learn how your patient participation can shape future care through responsible involvement in cannabis innovation. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis  and medical cannabis.